JP2023538524A5 - - Google Patents
Info
- Publication number
- JP2023538524A5 JP2023538524A5 JP2023508065A JP2023508065A JP2023538524A5 JP 2023538524 A5 JP2023538524 A5 JP 2023538524A5 JP 2023508065 A JP2023508065 A JP 2023508065A JP 2023508065 A JP2023508065 A JP 2023508065A JP 2023538524 A5 JP2023538524 A5 JP 2023538524A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- item
- pharmaceutically acceptable
- compound according
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063061742P | 2020-08-05 | 2020-08-05 | |
| US63/061,742 | 2020-08-05 | ||
| PCT/US2021/044528 WO2022031838A1 (en) | 2020-08-05 | 2021-08-04 | Compositions for modulating splicing |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023538524A JP2023538524A (ja) | 2023-09-08 |
| JP2023538524A5 true JP2023538524A5 (enExample) | 2024-08-13 |
| JP7895554B2 JP7895554B2 (ja) | 2026-07-28 |
Family
ID=80117649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023508065A Active JP7895554B2 (ja) | 2020-08-05 | 2021-08-04 | スプライシングを調節する組成物 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20230331718A1 (enExample) |
| EP (1) | EP4192454B1 (enExample) |
| JP (1) | JP7895554B2 (enExample) |
| KR (1) | KR20230048106A (enExample) |
| CN (1) | CN116171153B (enExample) |
| AR (1) | AR123150A1 (enExample) |
| AU (1) | AU2021320763A1 (enExample) |
| CA (1) | CA3188104A1 (enExample) |
| IL (1) | IL300352B1 (enExample) |
| MX (1) | MX2023001558A (enExample) |
| TW (1) | TW202216697A (enExample) |
| UY (1) | UY39368A (enExample) |
| WO (1) | WO2022031838A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020163248A1 (en) | 2019-02-04 | 2020-08-13 | Skyhawk Therapeutics, Inc. | Methods and compositions for modulating splicing |
| WO2020163541A1 (en) | 2019-02-05 | 2020-08-13 | Skyhawk Therapeutics, Inc. | Methods and compositions for modulating splicing |
| KR102913697B1 (ko) * | 2019-02-05 | 2026-01-15 | 스카이호크 테라퓨틱스, 인코포레이티드 | 스플라이싱을 조절하는 방법 및 조성물 |
| KR102925385B1 (ko) | 2019-02-06 | 2026-02-11 | 스카이호크 테라퓨틱스, 인코포레이티드 | 스플라이싱을 조절하는 방법 및 조성물 |
| JP7603594B2 (ja) | 2019-02-06 | 2024-12-20 | スカイホーク・セラピューティクス・インコーポレーテッド | スプライシングを調節するための方法および組成物 |
| GB202106871D0 (en) * | 2021-05-13 | 2021-06-30 | Addex Pharmaceuticals Sa | Novel compounds |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2579949T3 (es) | 2010-02-05 | 2016-08-17 | Heptares Therapeutics Limited | Derivados de 1,2,4-triazin-4-amina |
| MX2020001425A (es) * | 2017-08-04 | 2020-08-06 | Skyhawk Therapeutics Inc | Metodos y composiciones para modular el empalme. |
| BR112020019373A2 (pt) | 2018-03-27 | 2020-12-29 | Ptc Therapeutics, Inc. | Compostos para o tratamento da doença de hutington |
| JP2021521200A (ja) * | 2018-04-10 | 2021-08-26 | スカイホーク・セラピューティクス・インコーポレーテッド | 癌の処置のための化合物 |
| WO2020163248A1 (en) * | 2019-02-04 | 2020-08-13 | Skyhawk Therapeutics, Inc. | Methods and compositions for modulating splicing |
| EP3920918A4 (en) | 2019-02-05 | 2022-11-16 | Skyhawk Therapeutics, Inc. | METHODS AND COMPOSITIONS FOR MODULATION OF SPLICING |
| KR102913697B1 (ko) * | 2019-02-05 | 2026-01-15 | 스카이호크 테라퓨틱스, 인코포레이티드 | 스플라이싱을 조절하는 방법 및 조성물 |
| WO2022031998A2 (en) * | 2020-08-05 | 2022-02-10 | Skyhawk Therapeutics, Inc. | Process for the preparation of intermediates useful in the preparation of compounds that modulate splicing |
-
2021
- 2021-08-04 CA CA3188104A patent/CA3188104A1/en active Pending
- 2021-08-04 MX MX2023001558A patent/MX2023001558A/es unknown
- 2021-08-04 UY UY0001039368A patent/UY39368A/es not_active Application Discontinuation
- 2021-08-04 CN CN202180062419.8A patent/CN116171153B/zh active Active
- 2021-08-04 WO PCT/US2021/044528 patent/WO2022031838A1/en not_active Ceased
- 2021-08-04 AU AU2021320763A patent/AU2021320763A1/en active Pending
- 2021-08-04 EP EP21852740.6A patent/EP4192454B1/en active Active
- 2021-08-04 TW TW110128712A patent/TW202216697A/zh unknown
- 2021-08-04 KR KR1020237007640A patent/KR20230048106A/ko active Pending
- 2021-08-04 IL IL300352A patent/IL300352B1/en unknown
- 2021-08-04 AR ARP210102177A patent/AR123150A1/es unknown
- 2021-08-04 JP JP2023508065A patent/JP7895554B2/ja active Active
-
2023
- 2023-01-31 US US18/162,085 patent/US20230331718A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024542188A5 (enExample) | ||
| JP2024542260A5 (enExample) | ||
| JP2004534774A5 (enExample) | ||
| RU2004137273A (ru) | Композиции и способ лечения инфекционных заболеваний крупного рогатого скота и свиней | |
| JP2023520047A5 (enExample) | ||
| WO1998046231A1 (en) | Muscarinic agonist compounds | |
| RU2003117476A (ru) | Аминотиазолы и их применение в качестве антагонистов рецептора аденозина | |
| JP2008511601A5 (enExample) | ||
| JP2014510774A5 (enExample) | ||
| JP2008505157A5 (enExample) | ||
| EP0277635A2 (en) | Novel polyamine derivatives | |
| RU2007130144A (ru) | Гетероциклические соединения в качестве антагонистов cccr2b | |
| JP2004523478A5 (enExample) | ||
| RU2403253C2 (ru) | Пуриновые производные для применения в качестве агонистов аденозинового рецептора а-2а | |
| JP2023553428A5 (enExample) | ||
| JP2024545787A5 (enExample) | ||
| KR0130977B1 (ko) | 항종양제로서 폴리아민 유도체 | |
| JP2007505044A5 (enExample) | ||
| JP2002527513A5 (enExample) | ||
| JPH06505265A (ja) | ヒスタミンｈ↓３受容体に対する作動的または拮抗的活性を有するイミダゾール誘導体 | |
| US5654484A (en) | Polyamine derivatives as antineoplastic agents | |
| JP2012506908A5 (enExample) | ||
| RU2003130644A (ru) | Производные ркарболина и их фармацевтическое применение против дипрессии и страха | |
| JP2008531585A5 (enExample) | ||
| EP0399519A2 (en) | Potentiating cell-mediated immunity utilizing polyamine derivatives |